Author/Editor
Keith Kohl
Publisher
Angel Publishing
Description
Biotech-focused newsletter that does short-term trading — from their website: “Our strategy here at Topline Trader is simple: Identity major catalyst events in drug development, and position ourselves to profit handsomely from the wild price swings that follow.”
If you’ve subscribed to Topline Trader, please click the stars below to indicate your rating for this newsletter, and please share any other feedback about your experience using the comment box below.
Investment Performance
Rating from 1 votes
Rating: 1.0/5. From 1 vote.
Your vote
- 5 Stars 0 Votes
- 4 Stars 0 Votes
- 3 Stars 0 Votes
- 2 Stars 0 Votes
- 1 Stars 1 Votes
Quality Of Writing/Analysis
Rating from 1 votes
Rating: 1.0/5. From 1 vote.
Your vote
- 5 Stars 0 Votes
- 4 Stars 0 Votes
- 3 Stars 0 Votes
- 2 Stars 0 Votes
- 1 Stars 1 Votes
Value For Price
Rating from 1 votes
Rating: 1.0/5. From 1 vote.
Your vote
- 5 Stars 0 Votes
- 4 Stars 0 Votes
- 3 Stars 0 Votes
- 2 Stars 0 Votes
- 1 Stars 1 Votes
Customer Service
Rating from 1 votes
Rating: 1.0/5. From 1 vote.
Your vote
- 5 Stars 0 Votes
- 4 Stars 0 Votes
- 3 Stars 0 Votes
- 2 Stars 0 Votes
- 1 Stars 1 Votes